1887

Abstract

Human adenovirus 4 (HAdV-4), the only serotype of the species HAdV-E to be isolated from man, was first identified by its association with outbreaks of acute respiratory disease in military recruits. To combat such outbreaks, a live, oral HAdV-4 vaccine that is delivered via an enteric-coated capsule was developed. This vaccine has been used for nearly 40 years and has been shown to be safe and efficacious. In this study, the complete DNA sequence (35 994 bp) of the vaccine strain is described and its genetic content is analysed. Phylogenetic comparisons confirmed that the closest sequenced relative of HAdV-4 is another serotype of HAdV-E that infects chimpanzees (SAdV-25) and that the great majority of genes in HAdV-E are related most closely to HAdV-B genes. By using the sequence data, a system was constructed to facilitate production of replication-competent HAdV-4 recombinants.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80386-0
2004-11-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/11/vir853361.html?itemId=/content/journal/jgv/10.1099/vir.0.80386-0&mimeType=html&fmt=ahah

References

  1. Barraza, E. M., Ludwig, S. L., Gaydos, J. C. & Brundage, J. F. ( 1999; ). Reemergence of adenovirus type 4 acute respiratory disease in military trainees: report of an outbreak during a lapse in vaccination. J Infect Dis 179, 1531–1533.[CrossRef]
    [Google Scholar]
  2. Benkő, M., Harrach, B. & Russell, W. C. ( 2000; ). Family Adenoviridae. In Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses, pp. 227–238. Edited by M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle & R. B. Wickner. San Diego: Academic Press.
  3. Burgert, H. G., Ruzsics, Z., Obermeier, S., Hilgendorf, A., Windheim, M. & Elsing, A. ( 2002; ). Subversion of host defense mechanisms by adenoviruses. Curr Top Microbiol Immunol 269, 273–318.
    [Google Scholar]
  4. Chanock, R. M., Ludwig, W., Heubner, R. J., Cate, T. R. & Chu, L. W. ( 1966; ). Immunization by selective infection with type 4 adenovirus grown in human diploid tissue cultures. I. Safety and lack of oncogenicity and tests for potency in volunteers. JAMA 195, 445–452.[CrossRef]
    [Google Scholar]
  5. Chengalvala, M., Lubeck, M. D., Davis, A. R., Mizutani, S., Molnar-Kimber, K., Morin, J. & Hung, P. P. ( 1991; ). Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Vaccine 9, 485–490.[CrossRef]
    [Google Scholar]
  6. Chengalvala, M. V., Bhat, B. M., Bhat, R., Lubeck, M. D., Mizutani, S., Davis, A. R. & Hung, P. P. ( 1994; ). Immunogenicity of high expression adenovirus–hepatitis B virus recombinant vaccines in dogs. J Gen Virol 75, 125–131.[CrossRef]
    [Google Scholar]
  7. Chengalvala, M. V., Bhat, B. M., Bhat, R. A., Dheer, S. K., Lubeck, M. D., Purcell, R. H. & Murthy, K. K. ( 1997; ). Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. Vaccine 15, 335–339.[CrossRef]
    [Google Scholar]
  8. Crawford-Miksza, L. K. & Schnurr, D. P. ( 1996; ). Adenovirus serotype evolution is driven by illegitimate recombination in the hypervariable regions of the hexon protein. Virology 224, 357–367.[CrossRef]
    [Google Scholar]
  9. Crawford-Miksza, L. K., Nang, R. N. & Schnurr, D. P. ( 1999; ). Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease. J Clin Microbiol 37, 1107–1112.
    [Google Scholar]
  10. Davison, A. J., Akter, P., Cunningham, C. & 7 other authors ( 2003a; ). Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes. J Gen Virol 84, 657–663.[CrossRef]
    [Google Scholar]
  11. Davison, A. J., Benkő, M. & Harrach, B. ( 2003b; ). Genetic content and evolution of adenoviruses. J Gen Virol 84, 2895–2908.[CrossRef]
    [Google Scholar]
  12. Farina, S. F., Gao, G., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J., Ertl, H. C. J. & Wilson, J. M. ( 2001; ). Replication-defective vector based on a chimpanzee adenovirus. J Virol 75, 11603–11613.[CrossRef]
    [Google Scholar]
  13. Gruber, W. C., Russell, D. J. & Tibbetts, C. ( 1993; ). Fiber gene and genomic origin of human adenovirus type 4. Virology 196, 603–611.[CrossRef]
    [Google Scholar]
  14. Hay, R. T. ( 1985; ). Origin of adenovirus DNA replication. Role of the nuclear factor I binding site in vivo. J Mol Biol 186, 129–136.[CrossRef]
    [Google Scholar]
  15. Hilleman, M. R. & Werner, J. H. ( 1954; ). Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 85, 183–188.[CrossRef]
    [Google Scholar]
  16. Jacobs, S. C., Stephenson, J. R. & Wilkinson, G. W. G. ( 1992; ). High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. J Virol 66, 2086–2095.
    [Google Scholar]
  17. Kidd, A. H., Garwicz, D. & Öberg, M. ( 1995; ). Human and simian adenoviruses: phylogenetic inferences from analysis of VA RNA genes. Virology 207, 32–45.[CrossRef]
    [Google Scholar]
  18. Kitchingman, G. R. ( 1985; ). Sequence of the DNA-binding protein of a human subgroup E adenovirus (type 4): comparisons with subgroup A (type 12), subgroup B (type 7), and subgroup C (type 5). Virology 146, 90–101.[CrossRef]
    [Google Scholar]
  19. Li, Q.-G. & Wadell, G. ( 1988; ). The degree of genetic variability among adenovirus type 4 strains isolated from man and chimpanzee. Arch Virol 101, 65–77.[CrossRef]
    [Google Scholar]
  20. Li, Y. & Wold, W. S. M. ( 2000; ). Identification and characterization of a 30K protein (Ad4E3-30K) encoded by the E3 region of human adenovirus type 4. Virology 273, 127–138.[CrossRef]
    [Google Scholar]
  21. Lubeck, M. D., Davis, A. R., Chengalvala, M. & 8 other authors ( 1989; ). Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc Natl Acad Sci U S A 86, 6763–6767.[CrossRef]
    [Google Scholar]
  22. Lubeck, M. D., Natuk, R. J., Chengalvala, M. & 12 other authors (1994; ). Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res Hum Retrovir 10, 1443–1449.[CrossRef]
    [Google Scholar]
  23. Mason, B. B., Davis, A. R., Bhat, B. M. & 9 other authors ( 1990; ). Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron. Virology 177, 452–461.[CrossRef]
    [Google Scholar]
  24. McNeill, K. M., Hendrix, R. M., Lindner, J. L., Benton, F. R., Monteith, S. C., Tuchscherer, M. A., Gray, G. C. & Gaydos, J. C. ( 1999; ). Large, persistent epidemic of adenovirus type 4-associated acute respiratory disease in U.S. army trainees. Emerg Infect Dis 5, 798–801.[CrossRef]
    [Google Scholar]
  25. Patterson, L. J., Prince, G. A., Richardson, E., Alvord, W. G., Kalyan, N. & Robert-Guroff, M. ( 2002; ). Insertion of HIV-1 genes into Ad4ΔE3 vector abrogates increased pathogenesis in cotton rats due to E3 deletion. Virology 292, 107–113.[CrossRef]
    [Google Scholar]
  26. Pring-Åkerblom, P. & Adrian, T. ( 1995; ). Sequence characterization of the adenovirus 31 fibre and comparison with serotypes of subgenera A to F. Res Virol 146, 343–354.[CrossRef]
    [Google Scholar]
  27. Pring-Åkerblom, P., Trijssenaar, F. E. J. & Adrian, T. ( 1995; ). Sequence characterization and comparison of human adenovirus subgenus B and E hexons. Virology 212, 232–236.[CrossRef]
    [Google Scholar]
  28. Rubin, B. A. & Rorke, L. B. ( 1994; ). Adenovirus vaccines. In Vaccines, 2nd edn, pp. 475–502. Edited by S. A. Plotkin & E. A. Mortimer. Philadelphia, PA: W. B. Saunders.
  29. Scarpini, C., Arthur, J., Efstathiou, S., McGrath, Y. & Wilkinson, G. ( 1999; ). Herpes simplex virus and adenovirus vectors. In DNA Viruses: A Practical Approach, pp. 267–306. Edited by A. J. Cann. Oxford: Oxford University Press.
  30. Tacket, C. O., Losonsky, G., Lubeck, M. D., Davis, A. R., Mizutani, S., Horwith, G., Hung, P., Edelman, R. & Levine, M. M. ( 1992; ). Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. Vaccine 10, 673–676.[CrossRef]
    [Google Scholar]
  31. Tarassishin, L., Szawlowski, P., McLay, J., Kidd, A. H. & Russell, W. C. ( 1999; ). Adenovirus core protein VII displays a linear epitope conserved in a range of human adenoviruses. J Gen Virol 80, 47–50.
    [Google Scholar]
  32. Taylor, P. ( 1986; ). A computer program for translating DNA sequences into protein. Nucleic Acids Res 14, 437–441.[CrossRef]
    [Google Scholar]
  33. Thompson, J. D., Higgins, D. G. & Gibson, T. J. ( 1994; ). clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673–4680.[CrossRef]
    [Google Scholar]
  34. Tokunaga, O., Shinagawa, M. & Padmanabhan, R. ( 1982; ). Physical mapping of the genome and sequence analysis at the inverted terminal repetition of adenovirus type 4 DNA. Gene 18, 329–334.[CrossRef]
    [Google Scholar]
  35. Tokunaga, O., Yaegashi, T., Lowe, J., Dobbs, L. & Padmanabhan, R. ( 1986; ). Sequence analysis in the E1 region of adenovirus type 4 DNA. Virology 155, 418–433.[CrossRef]
    [Google Scholar]
  36. Wilkinson, G. W. G. & Akrigg, A. ( 1992; ). Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res 20, 2233–2239.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80386-0
Loading
/content/journal/jgv/10.1099/vir.0.80386-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error